Medexprim is very proud to start its new collaboration in the H2020 EU CHAIMELEON project.
CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for cancer management. By 2024, an EU-wide repository will be built as a distributed infrastructure in full compliance with legal and ethics regulations in the involved countries.
Clinical partners and external collaborators will populate the Repository with multimodality (MR, CT, PET/CT) imaging and related clinical data for historic and newly diagnosed breast, lung, prostate and colorectal cancer patients.
Medexprim is involved in two complementary ways:
- First as a contributor to the winning consortium. Medexprim’ roles cover legal, interoperability, platform architecture and internal consulting for data integration.
- Then through Karine Seymour’s key role in the project as the designated technical coordinator of the consortium: « I am very proud and excited to take part to this ambitious EU project, says Karine. It follows the Primage project in which we were already involved. It’s a big challenge, but it’s 100% in line with Medexprim’s core mission and expertise. We were waiting for such a program to get recognition from our peers and to establish our notoriety. Now, we have to deliver ! »
The first milestone will be on October 2021 with the first clinical datasets made available. More information
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 952172.